Distribution and characteristics of COPD phenotypes – results from the Polish sub-cohort of the POPE study

References

• TravisWDCostabelUHansellDMATS/ERS Committee on Idiopathic Interstitial PneumoniasAn official American Thoracic Society/European Respiratory Society Statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumoniasAm J Respir Crit Care Med2013188673374824032382
   PubMed Web of Science ®Google Scholar
• VogelmeierCFCrinerGJMartinezFJGlobal strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD executive summaryEur Respir J2017493 pii: 1700214
   Web of Science ®Google Scholar
• BarrechegurenMEsquinasCMiravitllesMThe asthma-chronic obstructive pulmonary disease overlap syndrome (ACOS): opportunities and challengesCurr Opin Pulm Med2015211747925405671
   PubMed Web of Science ®Google Scholar
• GouldNSMinEGauthierSChuHWMartiRDayBJAging adversely affects the cigarette smoke-induced glutathione adaptive response in the lungAm J Respir Crit Care Med201018291114112220622027
   PubMed Web of Science ®Google Scholar
• MatkovicZTudoricNMiravitllesMImpact of chronic bronchial infection in the lung and beyondEur Respir Mon2013604657
   Google Scholar
• WeissSTWhat genes tell us about the pathogenesis of asthma and chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2010181111170117320133923
   PubMed Web of Science ®Google Scholar
• Torres-DuqueCMaldonadoDPérez-PadillaREzzatiMViegiGForum of International Respiratory Studies (FIRS) Task Force on Health Effects of Biomass ExposureBiomass fuels and respiratory diseases: a review of the evidenceProc Am Thorac Soc20085557759018625750
   PubMedGoogle Scholar
• HnizdoESullivanPABangKMWagnerGAssociation between chronic obstructive pulmonary disease and employment by industry and occupation in the US population: a study of data from the Third National Health and Nutrition Examination SurveyAm J Epidemiol2002156873874612370162
   PubMed Web of Science ®Google Scholar
• KoblizekVChlumskyJZindrVCzech Pneumological and Phthisiological SocietyChronic obstructive pulmonary disease: official diagnosis and treatment guidelines of the Czech Pneumological and Phthisiological Society; a novel phenotypic approach to COPD with patient-oriented careBiomed Pap Med Fac Univ Palacky Olomouc Czech Repub2013157218920123733084
   PubMed Web of Science ®Google Scholar
• HanMKAgustiACalverleyPMChronic obstructive pulmonary disease phenotypes: the future of COPDAm J Respir Crit Care Med2010182559860420522794
   PubMed Web of Science ®Google Scholar
• MiravitllesMSoler-CataluñaJJCalleMSpanish COPD guidelines (GesEPOC) 2017. Pharmacological treatment of stable chronic obstructive pulmonary diseaseArch Bronconeumol201753632433528477954
   PubMed Web of Science ®Google Scholar
• MiravitllesMSoler-CataluñaJJCalleMSorianoJBTreatment of COPD by clinical phenotypes: putting old evidence into clinical practiceEur Respir J20134161252125623060631
   PubMed Web of Science ®Google Scholar
• ZhongNWangCZhouXLANTERN: a randomized study of QVA149 versus salmeterol/fluticasone combination in patients with COPDInt J Chron Obstruct Pulmon Dis20151011015102626082625
   PubMed Web of Science ®Google Scholar
• RossiAGuerrieroMCorradoAOPTIMO/AIPO Study GroupWithdrawal of inhaled corticosteroids can be safe in COPD patients at low risk of exacerbation: a real-life study on the appropriateness of treatment in moderate COPD patients (OPTIMO)Respir Res20141517725005873
   PubMed Web of Science ®Google Scholar
• GershonASCampitelliMACroxfordRCombination long-acting β-agonists and inhaled corticosteroids compared with long-acting β-agonists alone in older adults with chronic obstructive pulmonary diseaseJAMA2014312111114112125226477
   PubMed Web of Science ®Google Scholar
• RennardSICalverleyPMGoehringUMBredenbrökerDMartinezFJReduction of exacerbations by the PDE4 inhibitor roflumilast – the importance of defining different subsets of patients with COPDRespir Res20111211821272339
   PubMed Web of Science ®Google Scholar
• CosioBGSorianoJBLópez-CamposJLCHAIN StudyDistribution and outcomes of a phenotype based approach to guide COPD management: results from the CHAIN cohortPLoS One2016119e016077027684372
   PubMed Web of Science ®Google Scholar
• MiravitllesMBarrechegurenMRomán-RodríguezMFrequency and characteristics of different clinical phenotypes of chronic obstructive pulmonary diseaseInt J Tuberc Lung Dis201519899299826162367
   PubMed Web of Science ®Google Scholar
• ZbozinkovaZBarczykATkacovaRPOPE study: rationale and methodology of a study to phenotype patients with COPD in Central and Eastern EuropeInt J Chron Obstruct Pulmon Dis201611161162227042048
   PubMed Web of Science ®Google Scholar
• BestallJCPaulEAGarrodRGarnhamRJonesPWWedzichaJAUsefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary diseaseThorax199954758158610377201
   PubMed Web of Science ®Google Scholar
• JonesPWHardingGBerryPWiklundIChenWHKline LeidyNDevelopment and first validation of the COPD assessment testEur Respir J200934364865419720809
   PubMed Web of Science ®Google Scholar
• KoblizekVMilenkovicBBarczykAPhenotypes of COPD patients with a smoking history in Central and Eastern Europe: the POPE studyEur Respir J2017495 pii: 1601446
   Web of Science ®Google Scholar
• Calle RubioMCasamorRMiravitllesMIdentification and distribution of COPD phenotypes in clinical practice according to Spanish COPD Guidelines: the FENEPOC studyInt J Chron Obstruct Pulmon Dis2017122373238328848338
   PubMed Web of Science ®Google Scholar
• GolpeRSanjuán LópezPCano JiménezECastro AñónOPérez de LlanoLADistribution of clinical phenotypes in patients with chronic obstructive pulmonary disease caused by biomass and tobacco smokeArch Bronconeumol2014508318324 Spanish with English abstract24576449
   PubMed Web of Science ®Google Scholar
• AlshabanatAZafariZAlbanyanODairiMFitzGeraldJMAsthma and COPD overlap syndrome (ACOS): a systematic review and meta analysisPLoS One2015109e013606526336076
   PubMed Web of Science ®Google Scholar
• The Global Strategy for Asthma Management and Prevention, Global Initiative for Asthma (GINA)2014 Available from: http://www.ginasthma.org/Accessed September 27, 2017
   Google Scholar
• BarrechegurenMEsquinasCMiravitllesMThe asthma-COPD overlap syndrome: a new entity?COPD Res Pract201518
   Google Scholar
• European Environment Agency Report 5/2014 Available from: http://www.eea.europa.eu/publications/air-quality-in-europe-2014Accessed September 27, 2017
   Google Scholar
• ChenBHKanHDAir pollution and population health: a global challengeEnviron Health Prev Med20081329410119568887
   PubMedGoogle Scholar
• MenezesAMMontes deOMPérez-PadillaRIncreased risk of exacerbation and hospitalization in subjects with an overlap phenotype: COPD-asthmaChest2014145229730424114498
   PubMed Web of Science ®Google Scholar
• de OcaMMHalbertRJLopezMVThe chronic bronchitis phenotype in subjects with and without COPD: the PLATINO studyEur Respir J2012401283622282547
   PubMed Web of Science ®Google Scholar
• CaillaudDChanezPEscamillaRInitiatives BPCO scientific committee and investigatorsAsthma-COPD overlap syndrome (ACOS) vs “pure” COPD: a distinct phenotype?Allergy201772113714527501862
   PubMed Web of Science ®Google Scholar
• KimVHanMKVanceGBCOPDGene InvestigatorsThe chronic bronchitic phenotype of COPD: an analysis of the COPDGene StudyChest2011140362663321474571
   PubMed Web of Science ®Google Scholar
• SliwińskiPGóreckaDJassemEPierzchałaWPolish respiratory society guidelines for chronic obstructive pulmonary diseasePneumonol Alergol Pol2014823227263 Polish with English abstract24793150
   PubMedGoogle Scholar
• TudoricNKoblizekVMiravitllesMGOLD 2017 on the way to phenotypic approach? Analysis from the phenotypes of COPD in Central and Eastern Europe (POPE) cohortEur Respir J2017494160251828446560
   PubMed Web of Science ®Google Scholar